Redmile Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-979,108
Closed -$116M 89
2021
Q1
$116M Buy
+979,108
New +$115M 1.63% 18
2019
Q1
Sell
-419,900
Closed -$38.2M 85
2018
Q4
$38.2M Buy
+419,900
New +$39.2M 1.54% 24
2014
Q3
Sell
-589,974
Closed -$37.6M 61
2014
Q2
$37.6M Buy
+589,974
New +$35.8M 4.56% 2

Other funds holding MDT

Redmile Group's MDT Position: Q2 2021 in Review

Redmile Group sold out of Medtronic (MDT) in Q2 2021, closing a stake of 979,108 shares — an estimated $116M sold.

Redmile Group first reported a position in MDT in Q2 2014 and held it in 3 quarters. The position peaked at $116M in Q1 2021. 2,005 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • Redmile Group reported no remaining Medtronic position as of Q2 2021 after selling out during the quarter.
  • Redmile Group sold 979,108 Medtronic shares in Q2 2021, an estimated $116M.
  • Redmile Group first reported a position in Medtronic in Q2 2014 and held it in 3 quarters.
  • Redmile Group's Medtronic position peaked at $116M in Q1 2021.
  • 2,005 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Redmile Group's 13F filing for Q2 2021, filed 16 Aug 2021.